Purchase Order N6311624P0566
Award Date 9/4/24
Potential Completion Date 4/8/25
Potential Value $29K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Biomerieux Inc. for a BioMerieux EMAG system. The $95,717.38 contract has a completion date of September 14, 2023 and was awarded on September 2, 2022. The original solicitation was a sole-source procurement citing 10 U.S.C. 2304(c)(1) to acquire the proprietary BioMerieux system for use in laboratories at the Naval Health Research Center in San Diego. The award is not associated with...
- This is a delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Biomerieux Inc. for the supply of BIOMERIEUX EMAG diagnostic equipment and related services. The firm-fixed-price contract, valued at $95,717.38, has a completion date of May 30, 2023. The contract was awarded under Biomerieux's existing Multiple Award Schedule (MAS) contract with the General Services Administration, which facilitates the company's provision of in vitro...
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order contract valued at $21,660.00 to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of a product called the "EASY MAG" on August 21, 2023. The contract, which has a completion date of February 6, 2024, does not have a set-aside designation. Biomerieux Inc. specializes in microbiological testing solutions and has provided a wide array of proprietary microbiology...
- This is a firm-fixed-price purchase order awarded by the Department of the Navy's Bureau of Medicine and Surgery to Biomerieux Inc., a global leader in in vitro diagnostics. The $128,293.98 contract is for the delivery of COST PER TEST REAGENTS and does not have a set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. division, provides a wide range of clinical diagnostic equipment, reagents, and supplies to various federal agencies, including the Departments of Veterans Affairs,...
- This is a $25,640.80 firm fixed price purchase order awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a manufacturer of in vitro diagnostic products, for the supply of reagents and consumables. The award has a total small business set-aside designation and a period of performance through September 30, 2022. The items being delivered include various VITEK microbial identification and antibiotic susceptibility testing products to support the operations of the Naval Health Clinic...
- This is a firm-fixed-price delivery order awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Biomerieux Inc. for a "Cost Per Test Laboratory Mass Spectrometer". The contract has a ceiling value of $101,033.92 and a period of performance ending on March 22, 2016. The contract does not have a set-aside designation. Biomerieux Inc., a global leader in in vitro diagnostics, is the prime contractor and has supplied its proprietary VITEK systems and...
- This is a $235,020.16 firm fixed price purchase order awarded by the Defense Health Agency to Biomerieux Inc., a foreign-owned, for-profit manufacturer of diagnostic goods. The contract is for pathogenic bacteria cost per reportable, with a completion date of June 30, 2023. The original solicitation requested responses in the prescribed SF1449 format, with pricing on the provided contract line items. Biomerieux Inc. is a leading global provider of in vitro diagnostic solutions, including...
- This is a firm fixed-price purchase order awarded by the Department of the Navy Bureau of Medicine and Surgery to Biomerieux Italia SPA, a for-profit organization, for the delivery of chemical reagents. The contract has a potential value of $258,853.10 and a period of performance ending on September 30, 2024. The contract does not have a set-aside designation. Biomerieux Italia SPA is an established federal contractor that provides medical and laboratory supplies, equipment, and services to U.S....
- This is a delivery order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the provision of reagents with a cost per test agreement, under the Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III). The contract has a firm fixed price and a potential value of $313,442.24. It was awarded on September 5, 2017 and is set to be completed by August 15, 2022. The contract...
- This is a firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a foreign-owned for-profit manufacturer of clinical diagnostic products. The contract is to provide Biomerieux reagents and supplies to be used with government-owned analyzers, as well as the lease of a Virtuo B-Unit module, for the period of October 1, 2022 to September 30, 2023. The potential value of the contract is $249,612.61. This procurement was a sole source award under FAR...
This is a firm-fixed-price purchase order awarded by the Bureau of Medicine and Surgery (part of the U.S. Navy) to Biomerieux Inc. for the procurement of Biomerieux EMAG reagents. The contract has a period of performance through April 8, 2025 and a ceiling value of $28,840.20. The requirement was sole-sourced to Biomerieux as the only known provider of the EMAG reagents needed by the Naval Health Research Center (NHRC) in San Diego. This purchase order is likely part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract or Federal Supply Schedule that Biomerieux holds with the Department of Defense to provide its in vitro diagnostic systems and consumables. The contract does not have a set-aside designation.
Generated 12/4/24, 10:09 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Biomerieux EMAG Reagents | N63116-24-Q-0566 | Department of the Navy Naval Supply Systems Command | Special Notice 1/1 | 8/19/24, 12:05 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.8k | 9/4/24 |